xAnts

Altimmune Explores Obesity Drug as Potential Treatment for Alcohol Use Disorder

Altimmune announces plans to investigate its lead obesity drug, pemvidutide, as a potential treatment for alcohol use disorder and related health conditions, including alcohol-associated liver disease. This clinical trial aims to explore the therapeu ...undefined